We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eastman Chemical (EMN) Announces Buyback Worth $500 Million
Read MoreHide Full Article
Eastman Chemical Company (EMN - Free Report) recently entered into an accelerated share repurchase (ASR) agreement with Barclays Bank PLC and Royal Bank of Canada to buyback $500 million of its common stock. The repurchase is in addition to earlier planned buybacks. The company is now targeting $1 billion of repurchases in 2021.
The company’s board also increased its share repurchase authorization by $2.5 billion. The ASR buyback will be under the February 2018 $2 billion Board share buyback authorization. Upon completion of the ASR, the company will have authorization to buyback another roughly $2.85 billion of shares.
The company projects roughly 80% of the share repurchases or 3.7 million shares under the ASR agreement on Dec 8, 2021, based on its closing price of $109.34 on Dec 6, 2021.
The ASR buybacks are forecast to be completed in the first quarter of 2022, with the total number of repurchased shares based on Eastman’s volume-weighted average price during the term of the agreement, minus a discount.
The share buyback under the authorization is expected to be implemented through purchases made from time to time in either or both open market and private transactions.
Eastman Chemical’s shares have increased 13.6% in the past year compared with a 15.4% rise of the industry.
Image Source: Zacks Investment Research
Eastman Chemical, in its last earnings call, stated that it is seeing sustained logistics challenges, supply-chain issues and higher raw material and energy costs as it enters the fourth quarter. It is hiking prices across its specialty product lines to offset higher costs.
It expects adjusted earnings per share of $8.80-$9.00 for 2021. It also anticipates free cash flow to reach $1.1 billion for the year.
Zacks Rank & Key Picks
Eastman Chemical currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the basic materials space are Celanese Corporation (CE - Free Report) , The Chemours Company (CC - Free Report) and Nucor Corporation (NUE - Free Report) .
Celanese has an expected earnings growth rate of 139.5% for the current year. The Zacks Consensus Estimate for current-year earnings has been revised 8.7% upward in the past 60 days.
Celanese beat the Zacks Consensus Estimate for earnings in each of the last four quarters. The company has a trailing four-quarter earnings surprise of roughly 12.7%, on average. The stock has surged around 22% in a year. CE currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Chemours has an expected earnings growth rate of 105.1% for the current year. The Zacks Consensus Estimate for the current year has been revised 10% upward in the past 60 days.
Chemours beat the Zacks Consensus Estimate for earnings in all of the last four quarters. The company has a trailing four-quarter earnings surprise of roughly 34.2%, on average. CC has increased around 20.8% over a year. CC currently sports a Zacks Rank #2.
Nucor has a projected earnings growth rate of 583.2% for the current year. The consensus estimate for the current year has been revised 7.2% upward in the past 60 days.
Nucor beat the Zacks Consensus Estimate for earnings in two of the last four quarters. NUE has a trailing four-quarter earnings surprise of 2.74%, on average. The company’s shares have gained around 97.5% in a year. It currently carries a Zacks Rank #2.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
Eastman Chemical (EMN) Announces Buyback Worth $500 Million
Eastman Chemical Company (EMN - Free Report) recently entered into an accelerated share repurchase (ASR) agreement with Barclays Bank PLC and Royal Bank of Canada to buyback $500 million of its common stock. The repurchase is in addition to earlier planned buybacks. The company is now targeting $1 billion of repurchases in 2021.
The company’s board also increased its share repurchase authorization by $2.5 billion. The ASR buyback will be under the February 2018 $2 billion Board share buyback authorization. Upon completion of the ASR, the company will have authorization to buyback another roughly $2.85 billion of shares.
The company projects roughly 80% of the share repurchases or 3.7 million shares under the ASR agreement on Dec 8, 2021, based on its closing price of $109.34 on Dec 6, 2021.
The ASR buybacks are forecast to be completed in the first quarter of 2022, with the total number of repurchased shares based on Eastman’s volume-weighted average price during the term of the agreement, minus a discount.
The share buyback under the authorization is expected to be implemented through purchases made from time to time in either or both open market and private transactions.
Eastman Chemical’s shares have increased 13.6% in the past year compared with a 15.4% rise of the industry.
Eastman Chemical, in its last earnings call, stated that it is seeing sustained logistics challenges, supply-chain issues and higher raw material and energy costs as it enters the fourth quarter. It is hiking prices across its specialty product lines to offset higher costs.
It expects adjusted earnings per share of $8.80-$9.00 for 2021. It also anticipates free cash flow to reach $1.1 billion for the year.
Zacks Rank & Key Picks
Eastman Chemical currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the basic materials space are Celanese Corporation (CE - Free Report) , The Chemours Company (CC - Free Report) and Nucor Corporation (NUE - Free Report) .
Celanese has an expected earnings growth rate of 139.5% for the current year. The Zacks Consensus Estimate for current-year earnings has been revised 8.7% upward in the past 60 days.
Celanese beat the Zacks Consensus Estimate for earnings in each of the last four quarters. The company has a trailing four-quarter earnings surprise of roughly 12.7%, on average. The stock has surged around 22% in a year. CE currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Chemours has an expected earnings growth rate of 105.1% for the current year. The Zacks Consensus Estimate for the current year has been revised 10% upward in the past 60 days.
Chemours beat the Zacks Consensus Estimate for earnings in all of the last four quarters. The company has a trailing four-quarter earnings surprise of roughly 34.2%, on average. CC has increased around 20.8% over a year. CC currently sports a Zacks Rank #2.
Nucor has a projected earnings growth rate of 583.2% for the current year. The consensus estimate for the current year has been revised 7.2% upward in the past 60 days.
Nucor beat the Zacks Consensus Estimate for earnings in two of the last four quarters. NUE has a trailing four-quarter earnings surprise of 2.74%, on average. The company’s shares have gained around 97.5% in a year. It currently carries a Zacks Rank #2.